Jaume Pons

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

Johanna Theruvath, Marie Ménard, Benjamin Smith et al. · Nature Medicine · 2022 · 239 citations · Full text

Tumor Eradication, Immunology, Immune Checkpoint Inhibitor +3

Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration

Jindong Ding, Lincoln V. Johnson, Rolf Herrmann et al. · Proceedings of the National Academy of Sciences · 2011 · 187 citations · Full text

The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity

Yasmina Abdiche, Yik A. Yeung, Javier Chaparro‐Riggers et al. · mAbs · 2015 · 183 citations · Full text

Immunology, Immune Regulation, Innate Immunity +24

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

Steven E. Kauder, Tracy C. Kuo, Ons Harrabi et al. · PLoS ONE · 2018 · 164 citations · Full text

Adaptive Immune System, Immunology, Immunotherapeutics +18

Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti‐NGF monoclonal antibody, using a repertoire of biosensors

Yasmina Abdiche, Dan Malashock, Jaume Pons · Protein Science · 2008 · 140 citations · Full text

Immunocytochemical Technique, Immunology, Neuropathic Pain +17